Selective inhibition of ADAM metalloproteases as a novel approach for modulating ErbB pathways in cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/17363546

Clin. Cancer Res. 2007 Mar 15 13 6 1892-902

Download in:

View as

General Info

PMID
17363546